1-propanol has been researched along with Coronary Disease in 13 studies
1-Propanol: A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.
propan-1-ol : The parent member of the class of propan-1-ols that is propane in which a hydrogen of one of the methyl groups is replaced by a hydroxy group.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of intravenous propranolol on left ventricular wall motion and hemodynamics were studied in 16 patients, 12 with significant coronary artery disease and four with chest pain but no coronary disease." | 3.65 | Left ventricular wall motion response to intravenous propranolol. ( Dinsmore, RE; Harthorne, JW; Shubrooks, SJ; Zir, LM, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JY | 1 |
| Kim, SM | 1 |
| Kim, SJ | 1 |
| Lee, EY | 1 |
| Kim, JR | 1 |
| Cho, KH | 1 |
| Castaño, G | 3 |
| Mas, R | 3 |
| Gámez, R | 1 |
| Fernández, J | 2 |
| Illnait, J | 3 |
| Fernández, L | 3 |
| Mendoza, S | 1 |
| Mesa, M | 1 |
| Gutiérrez, JA | 1 |
| López, E | 1 |
| Chen, JT | 1 |
| Wesley, R | 1 |
| Shamburek, RD | 1 |
| Pucino, F | 1 |
| Csako, G | 1 |
| Batista, J | 2 |
| Stüsser, R | 2 |
| Saéz, F | 1 |
| Pérez, B | 1 |
| Padrón, R | 1 |
| Sosa, F | 1 |
| Pereztol, O | 1 |
| Alemán, C | 1 |
| Pontigas, V | 1 |
| Lescay, M | 1 |
| Fernández, JC | 1 |
| Alvarez, E | 1 |
| MOUQUIN, M | 1 |
| MILOVANOVICH, JB | 1 |
| SAUVAN, R | 1 |
| VONTHRON, A | 1 |
| GROSGOGEAT, Y | 1 |
| Smolenskiĭ, VS | 1 |
| Abinder, AA | 1 |
| Shubrooks, SJ | 1 |
| Zir, LM | 1 |
| Dinsmore, RE | 1 |
| Harthorne, JW | 1 |
| Teta, MJ | 1 |
| Perlman, GD | 1 |
| Ott, MG | 1 |
| Harvengt, C | 1 |
| Desager, JP | 1 |
| Heller, F | 1 |
| Hulhoven, R | 1 |
| Singh, BN | 1 |
| Till, MR | 1 |
| Kelly, DT | 1 |
1 review available for 1-propanol and Coronary Disease
| Article | Year |
|---|---|
Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol.
Topics: Anticholesteremic Agents; Coronary Disease; Fatty Alcohols; Humans; Hyperlipidemias; Phytosterols; R | 2005 |
7 trials available for 1-propanol and Coronary Disease
| Article | Year |
|---|---|
Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects.
Topics: Adult; Blood Pressure; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Coronary Disease; Diab | 2017 |
Concomitant use of policosanol and beta-blockers in older patients.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Coronary Dise | 2004 |
Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study.
Topics: Anticholesteremic Agents; Cholesterol; Coronary Disease; Double-Blind Method; Fatty Alcohols; Female | 1996 |
Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients.
Topics: Anticholesteremic Agents; Aspirin; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; | 1998 |
Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
Topics: Aged; Anticholesteremic Agents; Coronary Disease; Double-Blind Method; Fatty Alcohols; Female; Human | 1999 |
Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
Topics: Aged; Anticholesteremic Agents; Cardiovascular System; Cholesterol; Cholesterol, HDL; Cholesterol, L | 2001 |
The effects of oxprenolol (Trasicor, Ciba 39089-Ba) on patterns of urinary sodium excretion in man.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Adult; Amino Alcohols; Cardiomyopathy, Hypertrophic; Circad | 1971 |
5 other studies available for 1-propanol and Coronary Disease
| Article | Year |
|---|---|
[Clinical and experimental study of a new vasodilator; p-hydroxyphenyl-methyl-phenoxyethylamino propanol (CAA 40)].
Topics: 1-Propanol; Arteritis; Congenital Abnormalities; Coronary Disease; Ear; Ephedrine; Propanols; Vasodi | 1959 |
[Beta-adrenergic blocking agents ATP and anabolic hormones in the treatment of ischemic heart disease].
Topics: 1-Propanol; Adenosine Triphosphate; Adrenergic beta-Antagonists; Anabolic Agents; Animals; Coronary | 1977 |
Left ventricular wall motion response to intravenous propranolol.
Topics: 1-Propanol; Adult; Angina Pectoris; Angiocardiography; Cardiac Catheterization; Cineangiography; Cor | 1975 |
Mortality study of ethanol and isopropanol production workers at two facilities.
Topics: 1-Propanol; Cause of Death; Coronary Disease; Ethanol; Humans; Lymphoma, Non-Hodgkin; Male; Occupati | 1992 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hyper | 1987 |